Neobe Therapeutics
5 known investors
Neobe Therapeutics is developing a synthetic biology platform to engineer programmable live biotherapeutic products—microbial "trojan horses"—that disrupt the microenvironment of solid tumours. The company aims to enable immunotherapy to work in patients with immune-excluded tumours, operating in cancer therapeutics.
Investors · 5
Also in the syndicate · 3
Cancer Research HorizonsDiscovery Park VenturesPioneer Grouplead
Funding
SEC filings, press & company announcements$2.3M disclosed across 1 round · 2024
- $2.3MraisedFeb 2024 · 2 sources
Pioneer Group (lead), 2048 Ventures, Cancer Research Horizons, Deep Science Ventures, Discovery Park Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Neobe Therapeutics do?
- Neobe Therapeutics is developing a synthetic biology platform to engineer programmable live biotherapeutic products—microbial "trojan horses"—that disrupt the microenvironment of solid tumours. The company aims to enable immunotherapy to work in patients with immune-excluded tumours, operating in cancer therapeutics.
- Who are Neobe Therapeutics's investors?
- Neobe Therapeutics's investors include 2048 Ventures, Deep Science Ventures.
- How much funding has Neobe Therapeutics raised?
- Neobe Therapeutics has disclosed $2.3M raised across 1 round.